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A B S T R A C T
We analyzed proliferation and differentiation of calvarial osteoblasts derived fromMsx2 deficient in comparison with
wild type mice. Calvarial osteoblast cultures from five to eight days old Msx2 deficient, heterozygous and wild type mice
were studied for difference in proliferation and differentiation. Proliferation rate was assessed by counting cell number,
BrdU and Calcein AM labeling. Differentiation was assessed by Von Kossa and alkaline phosphatase staining, northern
blot hybridization with bone differentiation markers, infection of cell cultures with retrovirus expressing GFP under the
control of type I collagen promoter fragment. At day six, cell number in cell culture derived fromMsx2 deficient mice was
20% lower then in culture from wild type mice. There were 16.8% BrdU labeled cells in cell culture from Msx2 deficient
mice, 20.9% in culture from heterozygous mice and 21.6% in culture from wild type mice. Cell cultures from Msx2 defi-
cient mice showed lower intensity of fluorescence when marked with Calcein AM then cultures from wild type mice. Von
Kossa staining showed increased mineralization and northern blot analysis showed increased levels of bone differentia-
tion markers in cell cultures derived from Msx2 deficient mice. GFP came on earlier in Msx2 deficient cultures after in-
fection with Col2.3 GFP retrovirus. We conclude that calvarial osteoblasts derived fromMsx2 deficient mice have a lower
rate of proliferation and demonstrate increased osteoblastic differentiation when compared to osteoblasts derived from
wild type mice.
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Introduction
Msx2 is a member of highly conserved Msx homeobox
gene family1. The vertebrate Msx gene family is related
to the Drosophila msh gene and includes Msx1, 2 and 3.
Msx1 and Msx2 function as transcriptional regulators
that control cellular proliferation and differentiation du-
ring embryonic development2. They are expressed in nu-
merous tissues at many stages of development while
Msx3 is primarily expressed in the central nervous sys-
tem. Strong expression of Msx2 is found at the extreme
ends of the osteogenic fronts of calvarial sutures. Msx2
deficient mice3 were viable but exhibited pleiotropic de-
fects of skeletal and ectodermal organs and appendages,
while heterozygous mice were unaffected. The calvarium
of adult Msx2 deficient mice contained a large, midline
foramen spanning the frontal bones, and the interpa-
rietal and supraoccipital bones were small and abnor-
mally shaped. Osteoprogenitors in Msx2 deficient osteo-
genic fronts were reduced by 46% at birth. Msx2 expres-
sion in these cells4,5 suggests that Msx2 is directly in-
volved in calvarial bone growth. Msx2 deficient mice also
have defects in limb endochondral bone formation6, as
well as defects of tooth7, hair follicle8, mammary gland3
and cerebellum development9.
Gain-of-function mutation of Msx2 causes Boston-
-type craniosynostosis, a condition caused by premature
closure of cranial sutures10. However, the molecular basis
of the relationship between this mutation and the dis-
ease has not been identified yet.
Msx2, homeodomain protein, is a transcription factor
expressed very early in primary osteoblastic culture and
inhibits collagen type I synthesis in ROS 17/2.8 cells5. It
also inhibits osteocalcin gene promoter in MC3T3E1
cells11.
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Msx1 and 2 do not require homeodomain DNA-bind-
ing sites for transcriptional repression12. Msx1 acts as
transcriptional factor by binding to TAAT binding pro-
tein13 while Msx2 inhibition of transcription is not quite
understood yet. Both Msx genes control osteogenesis by
regulating Runx2 expression2.
In our previous studies Msx2 was overexpressed in
primary chicken calvarial osteoblast culture. Osteoblast
differentiation of those cells was inhibited while anti-
sense Msx2 expression inhibited proliferation and caused
premature differentiation14. These results suggested that
one of the biological roles of Msx2 was to inhibit differen-
tiation and stimulate proliferation in preosteoblastic cells
in the osteogenic front of the sutures, therefore playing
an important role in the development of the skull.
To confirm these findings and our hypothesis, we ex-
tended studies into a mammalian system using Msx2 de-
ficient mice as a model to compare proliferation and dif-
ferentiation of calvarial osteoblast cultures derived from
Msx2 deficient and wild type mice. We assessed and com-
pared differentiation and proliferation rates of calvarial
osteoblast cells derived from wild type, heterozygous and
homozygous Msx2 deficient mice. Proliferation rate was
assessed by counting cell number, BrdU and CalceinAM
labeling. Differentiation assessment was performed by
Von Kossa staining, hybridization of total cell RNA to
collagen and osteocalcin probes and infection of the cells
with Col2.3 GFP retrovirus, that expresses GFP as osteo-
blasts differentiate15. Based on those experiments we
suggest that calvarial osteoblasts derived from Msx2 de-
ficient mice have a lower rate of proliferation and demon-
strate increased osteoblastic differentiation than cells
derived from wild type mice. Heterozygous mice did not
present significant differences in proliferation and differ-
entiation when compared to wild type mice.
Materials and Methods
Mice genotyping
Msx2 deficient mice were generated as described in
Satokata et al.3,16. Msx2 deficient mice were maintained
on liquid diet due to abnormal dentition and were bred in
C57BL/6J background. Animals were maintained in the
Center for Laboratory Animal Care at University of Con-
necticut Health Center (UCHC) and procedures approved
by UCHC Animal Care Committee. Male and female het-
erozygous animals were bred to produce offspring for ex-
periments. After birth mice were notched and their tails
were clipped for genotyping3. Msx2 deficient, heterozy-
gous and wild type mice were genotyped by PCR using the
primers Sxg2 (neo; 5’-TCTGGACGAAGAGCATCAGG-
-3’), Sxg4 (5’-CCCTCTCTGTCCTCTAGGAC-3’) and Sxg5
(5’-GCCTGAGGGCAGCATAGGCT-3’). The wild type (359
bp) and mutant (650 bp) allele PCR products were ampli-
fied using Sxg4 and Sxg5, and Sxg2 and Sxg5, respec-
tively, in separate reactions using two stage PCR pro-
gram: 94°C for 1 min; 62°C for 1.5 min; 72°C for 2 min (3
cycles), 94°C for 1 min; 60°C for 2 min; 72°C for 2 min (30
cycles), 72°C for 5 min.
Primary mouse calvarial osteoblast culture
Calvariae were obtained, free of sutures and adherent
tissue, from 5–8 days old mice, placed into cold PBS with
penicillin/streptomycin (Life Technologies, Rockville, MD,
USA) and placed on 4°C for 48–36 hours until genotyping
was performed. According to genotyping results calva-
riae were divided into three groups: wild type, heterozy-
gous and homozygous, that are processed separately as
described in Dodig et al.15,17. Calvarial cells were isolated
by four sequential 15-minute digestions in 0.05% trypsin
(Life Technologies, Rockville, MD, USA) and 0.1% colla-
genase P (Roche Molecular Biochemicals, Indianapolis,
IN, USA) at 37°C on a rocking platform (85 rpm). Frac-
tions 2–4 were collected, resuspended in media, counted
and plated at 150000 cells per 35 mm dish. Cells were
grown in DMEM (Life Technologies, Rockville, MD, USA)
with 10% fetal bovine serum (Life Technologies, Rock-
ville, MD, USA) until confluence and then differentiation
media containing aMEM (Life Technologies, Rockville,
MD, USA), 10% fetal bovine serum, 50 mg/ml ascorbic
acid (Sigma-Aldrich, St. Louis, MO, USA) and 5 mM
b-glycerophosphate (Sigma-Aldrich, St. Louis, MO, USA)
was used to maintain the cells.
Assessment of differentiation
Alkaline Phosphatase staining – plates were rinsed
with PBS, fixed with citrate-acetone formaldehyde fixa-
tive, and stained for enzyme activity using 0.25% AS-BI
phosphate alkaline solution and fast red violet LB base
(Sigma-Aldrich, St. Louis, MO, USA, procedure No.86).
Plates were scanned using Umax Astra 4000U scanner
(Umax Technologies, Dallas, TX, USA).
Von Kossa staining – Briefly after fixation, cells were
exposed for 45 minutes to bright light in a 5% solution of
AgNO3 (Sigma-Aldrich, St. Louis, MO, USA). The reac-
tion was stopped with Na-thiosulphate18, cells were washed
and the cultures photographed. Plates were scanned us-
ing Umax Astra 4000U scanner.
Northern Blot analysis – RNA was isolated using
TRIZOL reagent (Life Technologies, Rockville, MD,
USA)19. 10 mg of total RNA was separated on 1% agarose
(BMA, Miami, FL, USA) 1.1M formaldehyde gel and
transferred to nylon membrane (Schleicher and Schuell,
Keene, NH, USA). Membranes were hybridized20 with
mouse type I collagen and osteocalcin [32P] CTP-labeled
probes. Hybridization was at 42°C. Signal was scanned
by 8-bit scanner Umax Astra 3400 and signal density was
assessed by embedded algorithms of ImageTool 3.0 soft-
ware (UTHSCSA, San Antonio, Texas, USA).
Assessment of proliferation
Cell counting – cell number was determined after
trypsinizing the cells from the plate by counting using
hemacytometer for three independent samplings per plate.
BrdU staining – at day 6 of the culture cells were in-
cubated in 10 mM BrdU (Sigma-Aldrich, St. Louis, MO,
USA) on 37°C for 90 min21. After incubation cells were
fixed in ethanol, permeabilized and denatured with 2 N
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HCl on 37°C for 1h and washed with 0.1 M borate buffer
(pH 8.5). Cells were incubated for 1h with monoclonal
anti-BrdU antibody (Sigma-Aldrich, St. Louis, MO, USA)
diluted 1:1000, followed with biotinylated secondary an-
tibody diluted 1:200 for 1h (Vectastain Elite ABC Kit,
Vector Laboratories, Burlingame, CA, USA). Avidin/bio-
tin-HRP reagent was added afterwards and positive cells
were visualized by adding DAB (Vectastain DAB kit, Vec-
tor Laboratories, Burlingame, CA, USA). Cells were coun-
terstained with hematoxylin and counted under the mi-
croscope. Difference between cultures was analyzed with
Statistica7 software (StatSoft, USA) and probability of
error (P) was determined by t-test.
Calcein-AM – at days 1, 3 and 6 of the culture, cells
were washed with PBS and treated with 2 µM CALCEIN-
-AM (Molecular Probes, Eugene, OR, USA) at 37°C for 20
min. Cells were washed with PBS again, fed with fresh
media and examined under Zeiss Axiovert 200 invert mi-
croscope (Zeiss, Göttingen, Germany). Dishes were
scanned under fluorescent optics using a 5x objective.
Signal density was assessed by embedded algorithms of




Differentiation of the culture derived from wild type
and Msx2 deficient mice was compared by observation of
type I collagen and osteocalcin mRNA, alkaline pho-
phatase staining, Von Kossa staining for minerals and ac-
tivity of osteoblast specific 2.3 kb fragment of collagen
promoter.
Mouse calvarial culture was observed at four different
time points: day 4, 9, 14 and 20 (Figure 1A). Difference in
differentiation became apparent in Von Kossa stained
plates at day 14 and remained at day 20. Cultures deri-
ved from Msx2 deficient mice were more mineralized at
later time points than culture derived from wild type ani-
mals. Cultures from heterozygous animals showed an in-
termediate phenotype. Northern blot analysis of the cul-
ture derived from Msx2 deficient mice showed upregu-
lation of collagen (Figure 1B, C) and osteocalcin (Figure
1B, D) at later time points.
Calvarial cultures from wild type and Msx2 deficient
mice were infected with ROSA Col2.3GFPemd virus.
Col2.3 is a 2.3 kb fragment of the rat Col1a1 promoter
that is active at a specific stage of osteoblast differentia-
tion. There were more cells positive for GFPemd in the
culture derived from Msx2 deficient than wild type mice
(Figure 2), while culture from heterozygous mice resem-
bled culture from wild type mice (data not shown).
Comparison of proliferation
Proliferation of the cell cultures from wild type, het-
erozygous and Msx2 deficient mice were compared by
BrdU and Calcein-AM staining.
At day 6, cell cultures from wild type, heterozygous
and Msx2 deficient mice were treated with BrdU in order
to determine number of cells in S-phase of the cell cycle,
which reflects the proliferation rate of the cultures. Cul-
ture from wild type mice had 21.6%, culture from hetero-
zygous mice had 20.9% and culture from Msx2 deficient
mice had 16.8% BrdU positive cells (Figure 3). Prolifera-
tion rates of cultures derived from wild type and Msx2
deficient mice presented statistically significant differ-
ence with p<0.05.
Cultures derived from wild type and Msx2 deficient
mice were incubated with Calcein-AM at days 1, 3 and 6
in order to visualize cell number difference. The culture
from wild type mice has more cells than the culture from
Msx2 deficient mice and difference became greater with
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Fig. 1. Comparison of differentiation by alkaline phosphatase,
Von Kossa staining and Northern blot analysis. Alkaline
phosphatase, Von Kossa staining (A) and northern blot analysis
(B) of collagen type I (Col) and osteocalcin (OC) of representatives
of three separate cultures (+/+ – wild type, KO/+ – heterozygous
and KO/KO – homozygous for Msx2 deficiency) show increased
differentiation in cultures derived from Msx2 deficient mice; in-
crease in signal density of Col (C) and OC (D) mRNA signals in
cell culture from Msx2 deficient mice.
KO
WT
d13 d17 d19 d21
Fig. 2. Comparison of differentiation by infection with ROSA
Col2.3 GFPemd. Culture derived from Msx2 deficient mice (KO)
showed earlier and stronger activation (days 19 and 20) of osteo-
blast specific Col2.3 promoter then culture from wild type mice
(WT). 30 mm plates were scanned using 5x magnification.
time (Figure 4A, B). Culture from heterozygous mice did
not differ from culture derived from wild type mice (data
not shown).
Disscusion
In these studies we examined the role of Msx2 in the
development of skull. In order to assess the function of
Msx2 in this process, we compared differentiation and
proliferation rates of primary calvarial osteoblast cul-
tures from Msx2 deficient mice, mice heterozygous for
Msx2 deficiency and wild type mice. We found that osteo-
blastic differentiation was induced in Msx2 deficient cul-
tures. Furthermore, the proliferation of Msx2 deficient
cultures was decreased. Those findings support the role
of Msx2 in inhibiting differentiation and stimulating pro-
liferation.
Msx2 is expressed primarily in cells at the extreme
end of the osteogenic fronts of the cranial sutures and in
the cells between the sutures. There is decreased or ab-
sent expression in the cells flanking the front5. Those re-
sults suggest that Msx2 could play the role in maintain-
ing the committed osteoblasts of osteogenic front in
undifferentiated stage as well as stimulating their prolif-
eration, enabling the growth of cranial bones.
Calvarial cultures from Msx2 deficient mice showed
decreased proliferation and increased differentiation. Di-
fferentiation was assessed by using well-known markers
of osteoblast differentiation as alkaline phosphatase, col-
lagen type I, osteocalcin, mineralization level, and a
retroviral vector expressing GFP under the control of
osteoblast specific 2.3 kb fragment of collagen type I
promoter22,23.
Boston type craniosynostosis is the human disease cau-
sed by gain-of-function mutation in MSX2 gene6. Trans-
genic mouse model with Msx2 overexpression has en-
hanced growth at the osteogenic fronts as well as in-
creased BrdU labeling when compared to normal mice4,24.
It is hypothesized that increased growth and prolifera-
tion of the cells of osteogenic ridges causes that neighbor-
ing calvarial bones to meet prematurely and in humans
that process could downregulate Msx2 expression, allow-
ing osteoblastic differentiation and premature closure of
the suture5.
Adult Msx2 deficient mice have large, midline fora-
men spanning the frontal bones of calvaria24. Skeletal
staining and alkaline phosphatase histochemistry indi-
cate delay in bone growth and ossification. BrdU labeling
of Msx2 deficient osteoprogenitors at osteogenic fronts is
reduced3. In that case, Msx2 absence is responsible for
decreased proliferation and inability of osteogenic ridges
to expand and proper suture closer is absent. Signifi-
cantly, the entire calvaria is missing in Msx1–/–;Msx2–/–
mutant, suggesting that Msx1 and Msx2 function to-
gether to regulate osteogenesis during calvaria develop-
ment3. They have critical and functionally redundant
roles in regulating calvarial morphogenesis2.
Another model for analysis of Msx2 function in osteo-
blast differentiation is Msx2 retroviral overexpression5






















Fig. 3. Comparison of cell number by BrdU staining. BrdU in-
corporation in 6 days old cells from culture derived from wild
type mice (+/+) was 21.6%, from culture derived from heterozy-
gous mice (KO/+) was 20.9% and from culture derived from
knock-out mice (KO/KO) was 16.8%. Difference between cultures

















Fig. 4. Comparison of cell number by calcein-AM staining. Cul-
ture from Msx2 deficient mice (KO) at days 3 and 6 had lower
cell number than culture from wild type mice (WT). 30 mm plates
were scanned using 5x magnification.
in primary culture of chick calvarial osteoblast cells that
prevents osteoblast differentiation. Expression of anti-
sense Msx2 mRNA decreases proliferation and acceler-
ates their differentiation.
Those findings are consistent with our results, con-
firming the hypothesized role of Msx2 as a factor inhibit-
ing differentiation and stimulating proliferation in regu-
lation of calvarial growth and proper closure of sutures.
Conclusions
Calvarial osteoblasts from Msx2 deficient mice display
decreased proliferation and increased differentiation. Trans-
duction of osteoblastic cells with ROSACol2.3GFPemd
and assessment of GFP induction tempo and level can be
an effective method to measure osteoblastic lineage pro-
gression. Our results support our original hypothesis
that Msx2 affects calvarial development by delaying osteo-
blastic differentiation in the osteogenic fronts of the su-
tures.
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USPOREDBA PROLIFERACIJE I DIFERENCIJACIJE KULTURE OSTEOBLASTA IZ TJEMENIH
KOSTIJU MSX2 KNOCK-OUT I DIVLJEG TIPA MI[A
S A @ E T A K
Analizirani i uspore|ivani su proliferacija i diferencijacija osteoblasta porijeklom iz Msx2 knock-out mi{a i divljeg
tipa. Uspostavljene su kulture osteoblasta iz tjemenih kostiju pet do osam dana starih mi{eva Msx2 knock-out homo-
zigota, heterozigota te divljeg tipa. Brzina proliferacije je odre|ena brojanjem stanica, te BrdU i Calcein AM bojanjem.
Tempo diferencijacije je odre|en bojanjem stanica na alkalnu fosfatazu, Von Kossa bojanjem na minerale, Northern
hibridizacijom biljega ko{tane diferencijacije, te infekcijom stani~ne kulture retrovirusom koji sadr`i GFP pod kon-
trolom promotorskog fragmenta kolagena tipa I. [esti dan, broj stanica u stani~noj kulturi Msx2 knock-out mi{eva je
bio 20% ni`i nego u kulturi iz divljeg tipa. U stani~noj kulturi Msx2 knock-out mi{eva, BrdU ozna~enih stanica,je bilo
16,8% u kulturi iz heterozigota 20,9%, a u kulturi iz divljeg tipa 21,6%. Prilikom Calcein AM ozna~avanja, stani~na
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kultura iz Msx2 knock-out mi{eva je imala slabiji intenzitet fluorescencije nego stani~na kultura iz divljeg tipa mi{eva.
Von Kossa bojanje je pokazalo poja~anu mineralizaciju u kulturi Msx2 knock-out mi{eva, dok je Northern hibridizacija
pokazala i poja~anu ekspresiju biljega ko{tane diferencijacije. GFP se pojavio ranije u kulturi Msx2 knock-out mi{eva
nakon infekcije s Col2.3 GFP retrovirusom. Zaklju~ujemo da osteoblasti tjemenih kostiju iz Msx2 knock-out mi{a spo-
rije proliferiraju te br`e diferenciraju nego osteoblasti iz mi{a divljeg tipa.
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